Glioblastoma multiforme

Glioblastoma multiforme (GBM), WHO classification name “glioblastoma”, is the most common and most aggressive malignant primary brain tumor in humans, involving glial cells and accounting for 52% of all functional tissue brain tumor cases and 20% of all intracranial tumors. GBM is rare, with incidence of 2–3 cases per 100,000 in Europe and North America. It presents two variants: giant cell glioblastoma and gliosarcoma. Treatment can involve chemotherapy, radiation and surgery.